|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Acute treatment of migraine headache显示文摘 | CHANG M RAPOPORT AM | 2009 | Tech Reg Anesth Pain Manag2009，13，1： | 1 |
| 2 | Acute treatment of migraine: established and emerging therapies显示文摘 | RAPOPORT AM | 2012 | Headache2012，522，： | 1 |
| 3 | Ultrasonic nanotherapy of pancreatic cancer:lessons from ultrasound imaging显示文摘 | Rapoport N Kennedy AM Shea JE | | 0，，01： | 1 |
| 4 | Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period显示文摘 | Meskunas CA Tepper S J Rapoport AM | 2006 | Headache2006，46，： | 1 |
| 5 | Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles显示文摘 | Rapoport NY Kennedy AM Shea JE | 2009 | J Control Release2009，138，3： | 1 |
| 6 | Frovatritan:pharmacological differences and clinical results显示文摘 | Rapoport AM | 2001 | Curr Med Res Opin2001，17，1： | 1 |
| 7 | Optimizing the dose of zolmitriptan(zolmig,311C90)for the acute treatment of migraine-a multicenter,double-blind,placebo-controlled,dose range-finding study显示文摘 | RAPOPORT AM RAMADAN NM ADELMAN JU | 1997 | Neurology1997，49，5： | 1 |
| 8 | Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles显示文摘 | Rapoport NY Kennedy AM Shea JE | | 0，，03： | 1 |
| 9 | Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles显示文摘 | Rapoport NY Kennedy AM Shea JE | | 0，，03： | 1 |
| 10 | Ultrasonic nanotherapy of pancreatic cancer:lessons from ultrasound imaging显示文摘 | Rapoport NY Kennedy AM Shea JE | | 0，，01： | 1 |
| 11 | Preventive migraine therapy: what is new显示文摘 | Rapoport AM Bigal ME | 2004 | Nelarol Sci2004，25，： | 1 |
| 12 | The neurodevelopmental model of schizophrenia: update 2005 显示文摘 | Rapoport JL Addington AM Frangou S | 2005 | Mol Psychiatry2005，10，5： | 1 |
| 13 | Preventive migraine therapy:what is new显示文摘 | Bigal ME | 2004 | Neurol Sci2004，25，： | 1 |
| 14 | Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period 显示文摘 | Meskunas CA Tepper SJ Rapoport AM | 2006 | Headache2006，46，： | 1 |
| 15 | Safety, tolerability, and effi- cacy of TEV-48125 for preventive treatment of high-frequency episodic migraine : amulticentre, randomised, double-blind, placebo-controlled, phase 2b study显示文摘 | Bigal ME Dodick DW Rapoport AM | 2015 | Lancet Neuro12015，14，11： | 1 |
| 16 | Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes 显示文摘 | Bigal ME Rapoport AM Sheftell FD | 2004 | Cephalalgia2004，24，48： | 1 |
| 17 | Role of antiepileptic drugs as preventive agents for migraine显示文摘 | Vikelis M Rapoport AM | 2010 | CNS Drugs2010，24，1： | 1 |
| 18 | New migraine preventive options: an update with pathophysiological considerations显示文摘 | Bigal ME Rapoport AM Sheftell FD | 2002 | Rev Hosp Clin Fac Med Sao Paulo2002，57，6： | 1 |
| 19 | Zolmitriptan nasal spray in the acute treatment of cluster headache : a meta-analysis of two studies显示文摘 | Hedlund C Rapoport AM Dodick DW | 2009 | Headache2009，49，9： | 1 |
| 20 | Preventive migraine therapy:what is new显示文摘 | Rapoport AM Bigal ME | 2004 | Neurol Sci2004，25，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员